179 related articles for article (PubMed ID: 24157729)
1. Synthesis and biological studies of steroidal pyran based derivatives.
Shamsuzzaman ; Dar AM; Khan Y; Sohail A
J Photochem Photobiol B; 2013 Dec; 129():36-47. PubMed ID: 24157729
[TBL] [Abstract][Full Text] [Related]
2. In vitro cytotoxcity and interaction of new steroidal oxadiazinanones with calf thymus DNA using molecular docking, gel electrophoresis and spectroscopic techniques.
Dar AM; Ishrat U; Yaseen Z; Shamsuzzaman ; Gatoo MA
J Photochem Photobiol B; 2015 Jul; 148():340-350. PubMed ID: 26005047
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, molecular docking and biological evaluation of new steroidal 4H-pyrans.
Uzzaman S; Dar AM; Sohail A; Bhat S; mustafa MF; Khan Y
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan; 117():493-501. PubMed ID: 24021949
[TBL] [Abstract][Full Text] [Related]
4. DNA Interaction Studies and In Vitro Cytotoxicity of Newly Synthesized Steroidal Imidazolidinones.
Dar AM; Gatoo MA; Ahmad A; Ahmad MS; Najar MH; Shamsuzzaman
J Fluoresc; 2015 Sep; 25(5):1377-87. PubMed ID: 26245453
[TBL] [Abstract][Full Text] [Related]
5. Spectroscopic, Viscositic, DNA Binding and Cytotoxic Studies of Newly Synthesized Steroidal Imidazolidines.
Dar AM; Shamsuzzaman ; Khan S
J Fluoresc; 2016 Mar; 26(2):639-49. PubMed ID: 26698876
[TBL] [Abstract][Full Text] [Related]
6. DNA binding, artificial nuclease activity and cytotoxic studies of newly synthesized steroidal pyrimidines.
Dar AM; Rah B; Mir S; Nabi R; Shamsuzzaman ; Gatoo MA; Mashrai A; Khan Y
Int J Biol Macromol; 2018 May; 111():52-61. PubMed ID: 29292141
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of new steroidal imidazo [1,2-a] pyridines: DNA binding studies, cleavage activity and in vitro cytotoxicity.
Dar AM; Shamsuzzaman ; Gatoo MA
Steroids; 2015 Dec; 104():163-75. PubMed ID: 26433147
[TBL] [Abstract][Full Text] [Related]
8. Enantiomeric fluoro-substituted benzothiazole Schiff base-valine Cu(II)/Zn(II) complexes as chemotherapeutic agents: DNA binding profile, cleavage activity, MTT assay and cell imaging studies.
Alizadeh R; Yousuf I; Afzal M; Srivastav S; Srikrishna S; Arjmand F
J Photochem Photobiol B; 2015 Feb; 143():61-73. PubMed ID: 25600265
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of copper(II) and zinc(II)-based potential chemotherapeutic compounds: their biological evaluation viz. DNA binding profile, cleavage and antimicrobial activity.
Tabassum S; Asim A; Arjmand F; Afzal M; Bagchi V
Eur J Med Chem; 2012 Dec; 58():308-16. PubMed ID: 23137447
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of steroidal imidazolidinthiones as potential apoptotic agents: Investigation by theoretical and experimental studies.
Dar AM; Nabi R; Mir S; Gatoo MA; Shamsuzzaman ; Lone SH
Bioorg Chem; 2018 Sep; 79():190-200. PubMed ID: 29772469
[TBL] [Abstract][Full Text] [Related]
11. New heterobimetallic Cu(II)-Sn2(IV) complex as potential topoisomerase I inhibitor: in vitro DNA binding, cleavage and cytotoxicity against human cancer cell lines.
Tabassum S; Afzal M; Arjmand F
J Photochem Photobiol B; 2012 Oct; 115():63-72. PubMed ID: 22884481
[TBL] [Abstract][Full Text] [Related]
12. Dinuclear manganese(II) complexes of hexaazamacrocycles bearing N-benzoylated pendant separated by aromatic spacers: Antibacterial, DNA interaction, cytotoxic and molecular docking studies.
Arthi P; Shobana S; Srinivasan P; Prabhu D; Arulvasu C; Kalilur Rahiman A
J Photochem Photobiol B; 2015 Dec; 153():247-60. PubMed ID: 26461484
[TBL] [Abstract][Full Text] [Related]
13. New modulated design and synthesis of quercetin-Cu(II)/Zn(II)-Sn2(IV) scaffold as anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo-I activity.
Tabassum S; Zaki M; Afzal M; Arjmand F
Dalton Trans; 2013 Jul; 42(27):10029-41. PubMed ID: 23715526
[TBL] [Abstract][Full Text] [Related]
14. New ruthenium(II) arene complexes of anthracenyl-appended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and cytotoxicity.
Ganeshpandian M; Loganathan R; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
Dalton Trans; 2014 Jan; 43(3):1203-19. PubMed ID: 24177707
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic insights into a novel chromone-appended Cu(II) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and HepG2 cancer cells.
Yousuf I; Arjmand F; Tabassum S; Toupet L; Khan RA; Siddiqui MA
Dalton Trans; 2015 Jun; 44(22):10330-42. PubMed ID: 25970097
[TBL] [Abstract][Full Text] [Related]
16. A novel silver iodide metalo-drug: experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathione.
Banti CN; Kyros L; Geromichalos GD; Kourkoumelis N; Kubicki M; Hadjikakou SK
Eur J Med Chem; 2014 Apr; 77():388-99. PubMed ID: 24681027
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and crystal structure determination of copper(II)-complex: In vitro DNA and HSA binding, pBR322 plasmid cleavage, cell imaging and cytotoxic studies.
Tabassum S; Zaki M; Ahmad M; Afzal M; Srivastav S; Srikrishna S; Arjmand F
Eur J Med Chem; 2014 Aug; 83():141-54. PubMed ID: 24953031
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure elucidation of a copper(II) Schiff-base complex: in vitro DNA binding, pBR322 plasmid cleavage and HSA binding studies.
Tabassum S; Ahmad M; Afzal M; Zaki M; Bharadwaj PK
J Photochem Photobiol B; 2014 Nov; 140():321-31. PubMed ID: 25222146
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, DNA binding, cleavage activity and cytotoxicity of copper(II) complexes.
Li MJ; Lan TY; Cao XH; Yang HH; Shi Y; Yi C; Chen GN
Dalton Trans; 2014 Feb; 43(7):2789-98. PubMed ID: 24336842
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, crystal structure, DNA interaction and anticancer activity of tridentate copper(II) complexes.
Li GY; Du KJ; Wang JQ; Liang JW; Kou JF; Hou XJ; Ji LN; Chao H
J Inorg Biochem; 2013 Feb; 119():43-53. PubMed ID: 23186647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
